Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...

Scientists have uncovered a gut-specific epigenetic aging mechanism that links inflammation and iron imbalance to cancer risk ...

The first clinical trial to move forward as part of the Van Andel Research Institute-Stand Up To Cancer (VARI-SU2C) Epigenetics Dream Team will target metastatic colorectal cancer, the second leading ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

A pair of medications that make malignant cells act as if they have a virus could hold new promise for treating colorectal cancers and other solid tumors, reports a new study. The preclinical research ...

Investigators from the UCLA Health Jonsson Comprehensive Cancer Center developed an artificial intelligence (AI) model, based on tumor-associated epigenetic factors, which they say can predict patient ...

The roots of cancer run deep. Indeed, they’re usually assumed to run all the way to the blighted bits of DNA we call oncogenic mutations. But what if they don’t have to run quite that deep? What if ...

DNA mutations in oncogenes and tumor suppressor genes drive tumorigenesis, but epigenetic modifications, such as DNA methylation, take center stage in a new era of cancer research. 1 In a study ...

Epigenetics play a significant role in cancer onset and spread, and scientists explore epigenetic regulators for their roles in carcinogenesis. In this webinar brought to you by The Scientist, Özgen ...

As people live longer, the gut quietly accumulates damage that can tip the balance between healthy tissue renewal and chronic ...

A new preclinical study by Van Andel Institute Professor Dr. Scott Rothbart and colleagues reveals how two epigenetic cancer medications approved for separate uses may hold promise for treating ...